MDSpire - Takeaway
Feature

Three AI-Enabled Analyses Highlight Context-Dependent Biomarkers in Early-Onset Colorectal Cancer

Biomarker discovery in colorectal cancer has traditionally focused on identifying molecular alterations with broad prognostic or predictive utility. However, evidence is increasingly suggesting that b...

Share

  • 1

    AI-driven studies at ASCO reveal ancestry influences colorectal cancer biomarkers.

  • 2

    Early-onset colorectal cancer shows unique molecular profiles linked to Hispanic/Latino ancestry.

  • 3

    Ancestry and social determinants are critical for precision medicine.

  • 4

    AI-HOPE analyzes complex datasets for actionable insights.

  • 5

    FOLFOX treatment responses vary by ancestry; TGF-beta may indicate poor prognosis.

Original Source(s)

Three AI-Enabled Analyses Highlight Context-Dependent Biomarkers in Early-Onset Colorectal Cancer

  • by Lisa Astor

  • March 23, 2026

Related Content

FDA Approves Chemoimmunotherapy Regimen for Hodgkin Lymphoma

Nivolumab (Opdivo) with doxorubicin, vinblastine, and dacarbazine (AVD) was approved today for adult and pediatric patients aged 12 years and older with previously untreated stage III or IV classical ...

MajesTEC-3: ‘Unprecedented’ Benefit in Previously Treated Multiple Myeloma

For patients with previously treated multiple myeloma, the greatest risk reduction yet achieved in a phase III clinical trial was reported with the BCMA-directed CD3 T-cell engager teclistamab-cqyv pl...

Coalition urges Congress to boost CDC tobacco prevention funding

The ADA joined a coalition urging Congress to provide $310 million for tobacco prevention and cessation programs at the CDC.